Global smart inhalers market was valued at USD 15.4 billion in 2023, driven by the increasing prevalence of chronic respiratory diseases (CRDs) such as asthma and chronic obstructive pulmonary disease (COPD). These smart inhalers, which combine traditional inhalation therapy with digital technology, are gaining popularity due to their ability to monitor medication use and provide real-time feedback to both patients and healthcare providers. The market is expected to grow at a CAGR of 19.4% during the forecast period of 2024-2032, with the values projected to reach USD 76.0 billion by 2032.Market Drivers
Several factors are contributing to the rapid growth of the global smart inhalers market:
1. Rising Incidence of Chronic Respiratory Diseases : The increasing number of people suffering from asthma, COPD, and other respiratory conditions is a key driver of market growth. These conditions require long-term management, and smart inhalers offer an efficient way to track medication adherence, reduce the frequency of attacks, and improve overall disease management.
2. Technological Advancements in Digital Health : Advances in digital health technology have enabled the development of smart inhalers that are connected to smartphones and wearable devices. These devices allow patients to monitor their medication usage and share the data with healthcare providers, improving treatment outcomes.
3. Rising Focus on Personalized Medicine : Smart inhalers are increasingly being used to support personalized medicine by collecting patient data to tailor treatment plans. This trend is driving market growth as healthcare providers seek to optimize treatments based on individual patient needs.
Get a Free Sample Report with Table of Contents: tinyurl.com/2984jzyp
Market Outlook
With a projected CAGR of 19.4%, the global smart inhalers market is expected to experience robust growth over the next decade. The market's value is anticipated to rise from USD 15.4 billion in 2023 to USD 76.0 billion by 2032. As awareness of the benefits of smart inhalers increases, particularly in managing chronic respiratory conditions, demand is expected to continue to surge.
Global Smart Inhalers Market : Competitor Landscape
1. Sensirion AG
2. AptarGroup Inc.
3. Teva Pharmaceutical Industries Ltd.
4. Novartis AG
5. Boehringer Ingelheim International AG
6. Findair Sp.zo.o.
7. Adherium